Topical IL-1-Ra for Treatment of Corneal Neovascularization
Status:
Terminated
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness and safety of
Interleukin-1-Receptor Antagonist eye drops for the treatment of corneal blood vessels.